1. Home
  2. KYMR vs LIF Comparison

KYMR vs LIF Comparison

Compare KYMR & LIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • LIF
  • Stock Information
  • Founded
  • KYMR 2015
  • LIF 2008
  • Country
  • KYMR United States
  • LIF United States
  • Employees
  • KYMR N/A
  • LIF N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • LIF
  • Sector
  • KYMR Health Care
  • LIF
  • Exchange
  • KYMR Nasdaq
  • LIF Nasdaq
  • Market Cap
  • KYMR 3.0B
  • LIF 3.1B
  • IPO Year
  • KYMR 2020
  • LIF N/A
  • Fundamental
  • Price
  • KYMR $42.30
  • LIF $43.44
  • Analyst Decision
  • KYMR Buy
  • LIF Strong Buy
  • Analyst Count
  • KYMR 16
  • LIF 7
  • Target Price
  • KYMR $54.00
  • LIF $48.00
  • AVG Volume (30 Days)
  • KYMR 456.9K
  • LIF 571.8K
  • Earning Date
  • KYMR 10-31-2024
  • LIF 02-11-2025
  • Dividend Yield
  • KYMR N/A
  • LIF N/A
  • EPS Growth
  • KYMR N/A
  • LIF N/A
  • EPS
  • KYMR N/A
  • LIF N/A
  • Revenue
  • KYMR $87,563,000.00
  • LIF $342,918,000.00
  • Revenue This Year
  • KYMR N/A
  • LIF $23.82
  • Revenue Next Year
  • KYMR $33.16
  • LIF $22.80
  • P/E Ratio
  • KYMR N/A
  • LIF N/A
  • Revenue Growth
  • KYMR 86.92
  • LIF 18.70
  • 52 Week Low
  • KYMR $22.35
  • LIF $26.00
  • 52 Week High
  • KYMR $53.27
  • LIF $52.77
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 41.34
  • LIF N/A
  • Support Level
  • KYMR $40.95
  • LIF N/A
  • Resistance Level
  • KYMR $44.17
  • LIF N/A
  • Average True Range (ATR)
  • KYMR 2.32
  • LIF 0.00
  • MACD
  • KYMR -0.33
  • LIF 0.00
  • Stochastic Oscillator
  • KYMR 16.07
  • LIF 0.00

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About LIF Life360 Inc. Common Stock

Life360 is the world's largest family-focused social network, with over 50 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

Share on Social Networks: